ReviewFrontiers in immunology2026
Pathological mechanisms and research progress of multilevel intervention therapy for coronary heart disease.
Zhengyu Tu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it